BioNeutra Global Corporation
BGACF
$0.067
$0.006911.48%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 87.12% | 66.76% | 49.34% | 28.58% | -90.36% |
| Total Depreciation and Amortization | -55.34% | -1.14% | -3.16% | -3.47% | -33.64% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -7.16% |
| Total Other Non-Cash Items | 434.38% | 147.71% | -72.47% | -83.49% | -52.78% |
| Change in Net Operating Assets | -113.25% | -97.68% | -89.56% | -29.98% | 420.55% |
| Cash from Operations | -137.39% | -132.15% | -102.03% | -19.97% | 630.60% |
| Capital Expenditure | -624.75% | -161.05% | 79.52% | 84.59% | 106.88% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -100.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 100.00% | 95.71% | 98.00% | 98.49% | 98.49% |
| Cash from Investing | -676.09% | -13.09% | 87.22% | 90.07% | 104.43% |
| Total Debt Issued | 115.85% | 92.95% | 102.77% | 102.77% | -33.52% |
| Total Debt Repaid | 5.11% | -43.70% | 36.75% | 37.05% | 30.13% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -201.66% | 13.67% | -39.99% | -50.28% | 21.10% |
| Cash from Financing | 17.98% | 181.91% | 238.91% | 233.09% | 4.03% |
| Foreign Exchange rate Adjustments | 163.25% | 73.36% | 125.66% | 113.00% | -784.46% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -115.87% | 79.28% | 91.36% | 1,181.86% | 145.95% |
